专栏名称: BioBAY
搭建交流与合作的生命科学生态圈
目录
相关文章推荐
河北交通广播  ·  【992 | 气象】雨+雾!明早出行注意安全! ·  昨天  
新北方  ·  男子江中钓到“手雷” ?警方回应→ ·  3 天前  
51好读  ›  专栏  ›  BioBAY

会议活动丨2024亚太健康与生命科学峰会报名开启:深度聚焦产业全景,抢占亚太市场新机遇

BioBAY  · 公众号  ·  · 2024-10-24 16:30

正文



2024亚太健康与生命科学峰会


亚洲创新,惠及全球


2024亚太健康与生命科学峰会将于2024年11月11日至12日在新加坡再度起航,艾社康亚洲携手新加坡经济发展局、新保集团杜克-新加坡国立大学全球健康研究所、新加坡国立大学苏瑞福公共卫生学院等战略合作伙伴,邀请近百位亚太地区健康与生命科学领域的政策制定者、行业领袖、发展伙伴、投资者和创新者相聚狮城,共同推动亚洲的创新合作,共促公平与可及性。



峰会亮点


0

1

人在书途不孤独

亚太健康与生命科学领袖的巅峰聚会


来自亚太地区10多个国家的150多位领袖和高级管理人员将齐聚一堂,参与为期一天半的精彩议程。

0

2

人在书途不孤独

跨行业协作推动健康与生命科学创新


议题涵盖全价值链,从亚太市场趋势与机遇、创新与监管合作,到健康融资与生命科学领域的投资趋势。特别设置气候变化与健康专题,聚焦这一复杂且对全行业有广泛影响的重大问题。

0

3

人在书途不孤独

促进合作、创新与市场准入的理想平台


此次峰会汇聚了来自政府、国际组织、行业协会、金融机构、学术与医疗机构,以及患者团体的核心成员,他们共同为提高医疗可及性作出贡献。


参会者收获


前沿洞察

聆听来自公共与私营部门的顶级专家分享他们在亚洲健康与生命科学领域的最新经验与观点。

区域网络拓展

与亚太地区健康与生命科学行业的政策制定者、发展伙伴和高管建立有价值的联系。

合作契机

利用非正式交流的机会,寻找行业内新的潜在合作伙伴,拓展业务合作空间。



2024 亚太健康与生命科学峰会

主要议题




11月11日, 新加坡

题1: 亚太市场增长故事

  • 亚太市场增长趋势、轨迹与机遇

  • 政策变化及其对行业发展和创新的影响

  • 跨部门合作以促进亚太地区生命科学行业的发展

主题2: 亚太生命科学创新格局

  • 展示: 亚洲生命科学领袖的创新解决方案

  • 领袖见解: 与政策和监管领导者的炉边谈话,探讨在亚太地区培养有利于创新和成功商业化的环境

主题3: 创造一个充满活力的生命科学市场

  • 生命科学生态系统案例展示: 支持区域扩展的CXO们

  • 通过合作推动区域内的成本效益创新

  • 创新融资和改进市场准入

主题4: 亚洲生命科学投资论坛

  • 培养亚太地区下一代冠军,从本地创新到全球成功

  • 生命科学领域的投资趋势


新加坡之夜

  • 邀请制闭门交流酒会



11月12日, 新加坡

专题讨论 1:气候变化对健康的影响,呼吁行业行动

  • 气候变化对人群健康和卫生系统的影响概述

  • 发展伙伴的气候变化与健康战略,以及工业界目前在气候变化与健康方面的参与情况

专题讨论 2:亚洲医疗健康行业的低碳化

  • 卫生部门当前的碳足迹

  • 减排策略,领先企业的实例

案例研究报告:亚洲气候变化与健康交叉领域的创新与合作

  • 成功的合作项目/创新产品和解决方案

  • 经验教训、最佳 做法和推广方法

专题讨论 3: 建设更具气候韧性的健康系统

  • 改善健康基础设施的韧性和增强健康系统响应能力的策略

  • 政策和资金机制

  • 气候解决方案在亚太地区的投资新趋势,突出与健康领域相关的投资机会


合作伙伴


战略合作伙伴


支持伙伴


确认演讲嘉宾(部分)


【Development partner/ Government Agency/ Academic Institution】


  • Deepali KHANNA, Vice President, Asia, The Rockefeller Foundation

  • Shyam BISHEN Head, Centre for Health and Healthcare; Member of the Executive Committee, World Economic Forum

  • Yoshihiro KAWAI, Chairman of Global Asia Insurance Partnership (GAIP); Chair, OECD lPPC & Senior Advisor to the Commissioner JFSA

  • Paul HULEATT, Counsellor (Health), Australian High Commission, Singapore; Regional Advisor - Indo-Pacific Regulatory Strengthening Program (RSP); Australian Therapeutic Goods Administration (TGA)

  • Ministry of Health  Indonesia

  • Joji SUGAWARA, Vice President, Health and Global Policy Institute (HGPI)

  • Vera SIESJÖ, Senior One Health Scientist, Asia Infrastructure Investment Bank (AIIB)

  • Jiadi YU, Chief Investment Officer, International Finance Corporation (IFC)

  • Carrie LIU, Lead, Health and Healthcare, World Economic Forum

  • Dawn CHAN, CEO, Centre for Impact and Practices (CIIP); Managing Director, Investments, Temasek Trust Capital

  • Holly WHEELER, Principal, Office of Strategic Affairs, Reaching the Last Mile, UAE President Office

  • Giles NEWMARCH, Senior Investment Officer, lFC-International Finance Corporation (World Bank)

  • Wenfeng GONG, Senior Strategy Officer, China Office, Bill & Melinda Gates Foundation

  • Ryan MACFARLANE, Vice President, Access Partnership

  • Ritesh Thakkar, Senior Advisor and Head of Asia Pacific, Convergence Blended Finance

  • John ENG, Vice President Healthcare, Singapore Economic Development Board (EDB)

  • Hwee Ching ANG, Deputy Chief Executive OfficerExperimental Drug Development Centre (EDDC)

  • Yuan Lu HO, Co-lead, ASEAN Diagnostics Initiative, Vice President, Outreach & Talent Development, Diagnostics Development Hub

  • Lin SHI, Policy Director, China Office, the Pharmaceutical Research and Manufacturers of America (PhRMA)

  • Chen Ee LEE, Group Director, Innovation & Transformation, SingHealth

  • Jonas KARLSTRÖM, Associate Professor, Core Lead, Innovation in Global Health, SingHealth Duke-NUS Global Health Institute

  • Renzo R. GUINTO, Associate Professor, Global and Planetary Health, SingHealth Duke-NUS Global Health Institute, Duke-NUS Medical School, Singapore

  • Stéphanie J. BATOT, Deputy Director, Strategic Partnerships, SingHealth Duke-NUS Global Health Institute

  • Kelvin TAN, Head of Programme (Minor in Applied Ageing Studies), Singapore University of Social Sciences (SUSS)

  • Ankur MUTREJA, Director of Strategy, Partnerships and Communications, PATH


【Industry and Investment Leaders】


  • Dion Warren, I-SEA MCO Head, Takeda Pharmaceuticals

  • Siyuan CHEN VP, General Manager of Bristol Myers Squibb for China & Asia Cluster

  • Dale HUNTINGTON, Senior Director, Health Care Systems Policy, Johnson & Johnson

  • Angeline CHIN, Director APAC Sustainability,  Johnson & Johnson

  • Ye LI, Head of Corporate Affairs, Merck China

  • Peng ZHONG, Director, Social Innovation, Bayer Foundation

  • Pompy SRIDHAR, Director- India, MSD for Mothers

  • Coco LIU, ESG and Sustainability Lead, Philips Greater China

  • Jean-Gaetan Guillemaud, Vice President Corporate Affairs, Zuellig Pharma

  • Karen WU, Regional Lead of APAC Supply Chain, Roche Singapore

  • Biao CHENG, GM of Incubation, Microsoft Asia-Pacific Research & Development Group

  • Subramanyam YADAVALLI, CEO, Apollo Hospitals

  • Siddhartha BHATTACHARYA, Secretary General, Healthcare Federation of India (NATHEALTH)

  • Janice JIN, President, GenScript Asia Pacific

  • Jianguo YIN, Chairman, BioBAY

  • Nathan TIRTANA, President Director, PT Etana Biotechnologies Indonesia

  • Andrew WONG, General Manager of Shanghai Wotai Biotechnology Co., Ltd.

  • Sean SHI, Director & CEO, Sino-Innovax Biotec Pte Ltd

  • Christy MA, Chief Strategy Officer, SCG Cell Therapy

  • Ramesh RAJENTHERAN, CEO & Founder, MiyaHealth

  • Ben LI, Founder, Heals Healthcare

  • Arjun Sarker, CEO, Dawn Medical Technologies

  • Eugene HONG, Executive Director, Pharmaceuticals and Healthcare, DBS Bank

  • Jin Hoe KOH, Executive Director, Head, Capital Markets, Global Sales and Origination, SGX Group

  • Alessandro FALCONE, Head of Johnson & Johnson Innovation, JLABS Singapore

  • Anupama PURANIK, Managing Director, Russell Reynolds Associates

  • Faye ONG, Asia Head, Family Office and Philanthropic Advisory, Global Family Office, Citi Private Bank

  • Jolene OOI, Senior Principal, Healthcare and Emerging Technology Investments, EDBI Pte Ltd

  • May LO, Director, ABC Impact, Temasek Trust Asset Management

  • Vijay KARWAL, Managing Director, CBC Group

  • Kelly QIAO, Senior Principal, B Capital Group

  • Mia HU, Investment Director, Boehringer Ingelheim Venture Fund Asia

  • Stephen Ng, Managing Director; Head of Southeast Asia and South Asia; Chief Executive Officer of Singapore, CICC

  • Luming DENG, Chief Executive Officer, Haitong International Securities

  • Albert HUANG, Managing Director, YunFeng Capital

  • Fong Ming KOH, Investment Principal, LYFE Capital

  • Alva CHEN, Therapeutic Practice Leader, Healthcare, VMS Group

  • Anne XIE, Executive Director, Yijing Capital



2023年亚太健康与生命科学峰会

精彩回顾





为期两天的峰会通过八个不同的话题,聚焦亚洲生命科学创新和产业全景和战略性市场机遇 两大主题,汇集了来自亚洲近20个国家和地区的卫生系统领导人、国际组织代表、政策专家、学术领袖和生态系统合作伙伴。



2023年演讲嘉宾


向上滑动查看更多



峰会官网


扫描下方二维码 访问峰会官网



注册报名


扫描下方二维码 即刻注册报名







请到「今天看啥」查看全文